Innoviva: Q3 Earnings Snapshot

Innoviva: Q3 Earnings Snapshot – WTOP News

BURLINGAME, Calif. (AP) — BURLINGAME, Calif. (AP) — Innoviva Inc. (INVA) on Wednesday reported a loss of $73.9 million in its third quarter. On a per-share basis, the Burlingame, California-based company said it had a loss of $1.03. Earnings, adjusted for non-recurring costs, were 50 cents per share. The biopharmaceutical company posted revenue of $106.1...

Innoviva: Q3 Earnings Snapshot

BURLINGAME, Calif. (AP) — BURLINGAME, Calif. (AP) — Innoviva Inc. (INVA) on Wednesday reported a loss of $73.9 million in its third quarter.

Innoviva Reports Third Quarter 2026 Financial Results; Highlights Recent Company Progress

BURLINGAME, Calif.--(BUSINESS WIRE)--Innoviva, Inc. (NASDAQ: INVA) (“Innoviva” or the “Company”), a diversified biopharmaceutical company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics (IST), and a portfolio of strategic investments in healthcare assets, today reported financial results for the third quarter ended September 30, 2026, and more...

Innoviva (NASDAQ:INVA) Announces Quarterly Earnings Results, Misses Estimates By $1.55 EPS

Innoviva (NASDAQ:INVA – Get Free Report) posted its earnings results on Wednesday. The biotechnology company reported ($1.03) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.52 by ($1.55), FiscalAI reports. Innoviva had a return on equity of 28.03% and a net margin of 81.19%. The firm had revenue of $106.12 million […]